With latest innovation and most advanced generation of hematology line at Mega Lab, as annual tests exceed 30 million ...
Earnings call QIAGEN delivered Q1 2026 adjusted EPS of $0.54, in line with guidance, despite net sales of $492 million falling short of the 1% CER growth target (actual: -1% CER). The sales shortfall ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する